Terms: = Kidney tumors AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
1060 results:
1. [Total polyphenols of Cydonia oblonga inhibited proliferation and migration of renal cancer cells by PI3K/akt/mTOR pathway].
Abudurousuli K; Han MY; Hailati S; Maihemuti N; Talihati Z; Nueraihemaiti N; Dilimulati D; Baishan A; Aikebaier A; Zhou WT
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1052-1063. PubMed ID: 38621912
[TBL] [Abstract] [Full Text] [Related]
2. VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract] [Full Text] [Related]
3. Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.
Zhang C; Yu M; Hepperla AJ; Zhang Z; Raj R; Zhong H; Zhou J; Hu L; Fang J; Liu H; Liang Q; Jia L; Liao C; Xi S; Simon JM; Xu K; Liu Z; Nam Y; Kapur P; Zhang Q
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618952
[TBL] [Abstract] [Full Text] [Related]
4. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
5. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract] [Full Text] [Related]
6. EMX2 inhibits clear cell renal cell carcinoma progress via modulating akt/FOXO3a pathway.
Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
[TBL] [Abstract] [Full Text] [Related]
7. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit akt dephosphorylation and activate the akt-mTOR signaling pathway.
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
[TBL] [Abstract] [Full Text] [Related]
8. Pterostilbene and 6-shogaol exhibit inhibitory effects on sunitinib resistance and motility by suppressing the RLIP76-initiated Ras/ERK and akt/mTOR pathways in renal cancer cells.
Chiang IC; Chen SY; Hsu YH; Shahidi F; Yen GC
Eur J Pharmacol; 2024 Mar; 967():176393. PubMed ID: 38325792
[TBL] [Abstract] [Full Text] [Related]
9. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
10. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract] [Full Text] [Related]
11. SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/akt signaling pathway.
Wang HX; Zhao ZP; Du XY; Peng SL; Xu HY; Tang W; Yang L
Med Oncol; 2024 Jan; 41(2):54. PubMed ID: 38206539
[TBL] [Abstract] [Full Text] [Related]
12. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1.
Zhang J; Xie W; Ni B; Li Z; Feng D; Zhang Y; Han Q; Zhou H; Gu M; Tan R
Pharmacol Res; 2024 Feb; 200():107051. PubMed ID: 38190956
[TBL] [Abstract] [Full Text] [Related]
13. TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm.
Jia W; Chen L; Hou S; Kang C; Deng H
Medicine (Baltimore); 2024 Jan; 103(1):e36843. PubMed ID: 38181271
[TBL] [Abstract] [Full Text] [Related]
14. Effects of Purine Metabolism-Related
Yin W; Wang JH; Liang YM; Liu KH; Chen Y; Chen YS
Front Biosci (Landmark Ed); 2023 Dec; 28(12):354. PubMed ID: 38179759
[TBL] [Abstract] [Full Text] [Related]
15. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/akt/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.
Wang X; Yao L; Li Z; Zhang J; Ruan M; Mulati Y; Gan Y; Zhang Q
Int J Biol Sci; 2024; 20(2):643-663. PubMed ID: 38169650
[No Abstract] [Full Text] [Related]
16. Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
Tang F; Wang X; Liu T; Wang H; Wan Z; Fu Q; Zheng Z; Aersi M; Peng J
Urol J; 2024 Mar; 21(2):107-113. PubMed ID: 38168059
[TBL] [Abstract] [Full Text] [Related]
17. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through PI3K-akt signaling pathway.
Mi T; Zhang Z; Zhanghuang C; Jin L; Tan X; Liu J; Wu X; Li M; Wang J; Wang Z; Guo P; He D
Eur J Pharmacol; 2024 Feb; 964():176291. PubMed ID: 38158115
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
Kim GR; Kang JH; Kim HJ; Im E; Bae J; Kwon WS; Rha SY; Chung HC; Cho EY; Kim SY; Kim YC
Bioorg Chem; 2024 Feb; 143():107061. PubMed ID: 38154386
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Expression and Prognostic Implications of Krüppel-Like Factor 3 (KLF3) in Clear Cell Renal Cell Carcinoma.
Wan B; Zhang W; Deng X; Lu Y; Zhang Z; Yang Y
Crit Rev Eukaryot Gene Expr; 2024; 34(2):45-59. PubMed ID: 38073441
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent akt pathway activation.
Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
[TBL] [Abstract] [Full Text] [Related]
[Next]
